-
Follow the Money: Multi-omic Drug Discovery, Antibody Manufacturing, Biopolar Focus, More
Bio-IT World | Big money for small-batch antibodies, investment in understanding bipolar disorder, Mercy BioAnalytics nets Series A for detecting cancer biomarkers on the surface of tumor-derived extracellular vesicles; and more.
Apr 25, 2023
-
Embracing Automation to Integrate Medical Information and Safety Operations
Bio-IT World | Businesses depend on data to inform strategy and measure success across all industries. To benefit from automated workflows, life sciences organizations must integrate disparate systems. End-to-end, open architecture solutions facilitate communication between multiple platforms with minimal friction or tedious, time-consuming middle steps.
Apr 21, 2023
-
Bio-IT World Names 2023 Innovative Practices Winners
Bio-IT World| Bio-IT World today announced the 2023 Innovative Practices Awards winners. Six projects were honored. Companies involved in the winning entries included AbbVie, Bayer G4A; Carenostics; City of Hope; Generate Biomedicines; Hackensack Meridian Health; Higher Steaks; Regeneron Pharmaceuticals; SciBite; and Synthace.
Apr 19, 2023
-
Deep Proteome Sequencing Answers Longstanding Biology Question
Bio-IT World | Debate about whether RNA splicing events code for different proteins may finally be over, thanks to international research efforts and a new sequencing method that enumerates the massive number of human protein alterations in standard proteomics experiments.
Apr 18, 2023
-
NVIDIA and Mitsui Launch Japan’s First Generative AI Supercomputer to Accelerate Drug Discovery
Bio-IT World | In collaboration with NVIDIA, Mitsui, Japan, recently launched Tokyo-1, a supercomputer designed to boost Japan’s $100B pharmaceutical industry. The project features 16 NVIDIA DGX H100 AI systems—a part of NVIDIA’s NGX enterprise AI platform—to simulate high-resolution molecular dynamics and generate AI models for accelerated drug discovery.
Apr 14, 2023
